# Pioneer Group

> Pioneer Group is a VC fund in London backing Biotechnology and Medical. See 11 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 11
- Last investment: Apr 2026
- Lead investor: 9%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/pioneergrp
- X (Twitter): https://twitter.com/PioneerGrp
- Website: https://thepioneergroup.com

Pioneer Group is a vertically integrated platform curating innovation-focused ecosystems that increase the chance of business success.

## Contacts

5 contacts available for Pioneer Group. Shizune tracks 1 team members at Pioneer Group. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/pioneer-group-598a?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 36% |
| Medical | 2 | 18% |
| Therapeutics | 2 | 18% |
| Diabetes | 1 | 9% |
| Training | 1 | 9% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 45% |
| Venture - Series Unknown | 3 | 27% |
| Funding Round | 2 | 18% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Dr Imelda Juniarsih | Investment Associate Director | 3 | https://shizune.co/investors/profile/dr-imelda-juniarsih |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NunaBio | NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. | $8.8M | Venture - Series Unknown | Apr 30, 2026 |  |
| NuVision | NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham. | $6.5M | Venture - Series Unknown | Feb 05, 2026 |  |
| MNS | MNS is a UK-based medical technology company developing Miracus, a proprietary needle-free drug delivery platform designed to replace traditional hypodermic injections with a painless, thermally stable patch. |  | Seed | Nov 26, 2025 |  |
| ImmuONE | ImmuONE provides solutions for inhalation toxicology, irritation sensitization, alveolar clearance, and inflammation. If you want would contact them please contact them via phone call or email. | $777.4K | Seed | Mar 13, 2025 |  |
| Neobe Therapeutics | Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services. | $2.3M | Seed | Feb 29, 2024 |  |
| ImmuONE | ImmuONE provides solutions for inhalation toxicology, irritation sensitization, alveolar clearance, and inflammation. If you want would contact them please contact them via phone call or email. |  |  | Oct 25, 2023 |  |
| ImmuONE | ImmuONE provides solutions for inhalation toxicology, irritation sensitization, alveolar clearance, and inflammation. If you want would contact them please contact them via phone call or email. | $2.4M | Seed | Oct 25, 2023 |  |
| Bastion Therapeutics | Bastion Therapeutics is a preclinical stage biotechnology startup that uses proprietary platform technology to boost Tregs for the immune system | $840K |  | Sep 12, 2023 |  |
| NunaBio | NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. | $2.4M | Seed | Apr 20, 2023 |  |
| Kinomica | Kinomica is a proteomic-data science and diagnostics company specializing in cell signalling. Kinomica offers KScanTM, a powerful suite of advanced proprietary bioinformatics and phosphoproteomics analytical methods that can provide direct activity measurements of multiple endogenous kinases and comprehensive cell signalling network coverage. | $1.7M | Venture - Series Unknown | Mar 29, 2023 |  |

10 of 11 investments shown.

## Co-investors
- [Deep Science Ventures](https://shizune.co/investors/profile/deep-science-ventures) — VC Fund, 2 deals together
- [MEIF Proof-of-Concept & Early Stage Fund](https://shizune.co/investors/profile/meif-proof-of-concept-early-stage-fund) — VC Fund, 2 deals together
- [Mercia’s EIS funds](https://shizune.co/investors/profile/mercia-s-eis-funds) — VC Fund, 2 deals together
- [Mercia Ventures](https://shizune.co/investors/profile/mercia-ventures) — VC Fund, 2 deals together
- [2048 Ventures](https://shizune.co/investors/profile/2048-ventures) — VC Fund, 1 deal together
- [Ascension Life Fund](https://shizune.co/investors/profile/ascension-life-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Pioneer Group invest in?

Pioneer Group invests primarily in Biotechnology, Medical and Therapeutics startups, most often at Seed and Venture - Series Unknown stage. Most of the 11 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Pioneer Group?

Public channels for Pioneer Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Pioneer Group?

The team at Pioneer Group includes Dr Imelda Juniarsih (Investment Associate Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co